Sleep Quality After Nasosinusal Surgery in AERD Patients
NCT ID: NCT03627481
Last Updated: 2019-02-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
32 participants
INTERVENTIONAL
2018-09-01
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Characterisation of Nasal Polyps in Patients With and Without Aspirin-exacerbated Respiratory Disease
NCT03848156
The Effect of Early Radiofrequency Turbinate Reduction on Persistent Allergic Rhinitis
NCT05276336
Role of Montelukast in the Management of Chronic Rhinosinusitis With Nasal Polyps.
NCT05143502
Characterisation of the Nasal Microbiome in Patients With N-ERD
NCT04375293
Effect of Dietary Salicylate in Aspirin Exacerbated Respiratory Disease
NCT01778465
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AERD patients
Patients managed with Endoscopic sinus surgery for treatment of AERD.
Endoscopic sinus surgery
Endoscopic sinus surgery for nasal polyposis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endoscopic sinus surgery
Endoscopic sinus surgery for nasal polyposis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cumbersome nasal polyposis with poor treatment response
Exclusion Criteria
* Psychiatric disorder
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto Nacional de Enfermedades Respiratorias
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marcos Alejandro Jimenez Chobillon
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Instituto Nacional de Enfermedades Respiratorias
Mexico City, Mexico City, Mexico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C34-18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.